105 related articles for article (PubMed ID: 23902545)
1. TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?
Zattra E; Stan R; Russo I; Lo Nigro A; Peserico A; Alaibac M
Immunotherapy; 2013 Aug; 5(8):791-4. PubMed ID: 23902545
[No Abstract] [Full Text] [Related]
2. Drug-induced lupus erythematosus.
Pretel M; Marquès L; España A
Actas Dermosifiliogr; 2014; 105(1):18-30. PubMed ID: 23164669
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced lupus erythematosus.
Vedove CD; Del Giglio M; Schena D; Girolomoni G
Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
[TBL] [Abstract][Full Text] [Related]
4. Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al.
Fautrel B; Foltz V; Frances C; Bourgeois P; Rozenberg S
Arthritis Rheum; 2002 May; 46(5):1408-9; author reply 1409. PubMed ID: 12115253
[No Abstract] [Full Text] [Related]
5. The struggle to do no harm in clinical trials.
Schmidt C
Nature; 2017 Dec; 552(7685):S74-S75. PubMed ID: 29293235
[No Abstract] [Full Text] [Related]
6. Cutaneous lupus erythematosus and anti-TNF-alpha therapy: a case report with review of the literature.
Levine D; Switlyk SA; Gottlieb A
J Drugs Dermatol; 2010 Oct; 9(10):1283-7. PubMed ID: 20941956
[TBL] [Abstract][Full Text] [Related]
7. [Refractory subacute cutaneous lupus erythematosus treated with rituximab].
Cieza-Díaz DE; Avilés-Izquierdo JA; Ceballos-Rodríguez C; Suárez-Fernández R
Actas Dermosifiliogr; 2012; 103(6):555-7. PubMed ID: 22482740
[No Abstract] [Full Text] [Related]
8. [Thalidomide therapy of cutaneous lupus erythematosus].
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
Mikita N; Ikeda T; Ishiguro M; Furukawa F
J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
[TBL] [Abstract][Full Text] [Related]
10. IL-18 and skin inflammation.
Wittmann M; Macdonald A; Renne J
Autoimmun Rev; 2009 Sep; 9(1):45-8. PubMed ID: 19285156
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.
Ladizinski B; Shannon EJ; Sanchez MR; Levis WR
J Drugs Dermatol; 2010 Jul; 9(7):814-26. PubMed ID: 20677538
[TBL] [Abstract][Full Text] [Related]
12. Management of secondary immune deficiencies: what is the role of immunoglobulins?
Mouthon L; Fermand JP; Gottenberg JE
Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S56-67. PubMed ID: 23873315
[No Abstract] [Full Text] [Related]
13. [Thalidomide therapy for discoid lupus erythematosus].
Lyakhovisky A; Baum S; Shpiro D; Salomon M; Trau H
Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupus erythematosus.
McCauliffe DP
Semin Cutan Med Surg; 2001 Mar; 20(1):14-26. PubMed ID: 11308132
[TBL] [Abstract][Full Text] [Related]
15. Photosensitivity in lupus erythematosus.
Scheinfeld N; Deleo VA
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):272-9. PubMed ID: 15379880
[TBL] [Abstract][Full Text] [Related]
16. [Classification of dermatologic manifestations in lupus erythematosus].
Francès C; Barete S; Ayoub N; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):33-44. PubMed ID: 12746657
[TBL] [Abstract][Full Text] [Related]
17. The immunology of cutaneous lupus erythematosus.
Mooney E
Acta Derm Venereol Suppl (Stockh); 1989; 151():93-5; discussion 106-10. PubMed ID: 2696313
[TBL] [Abstract][Full Text] [Related]
18. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
Thomson KF; Goodfield MJ
J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.
Yoshimasu T; Nishide T; Seo N; Hiroi A; Ohtani T; Uede K; Furukawa F
Clin Exp Immunol; 2004 May; 136(2):245-54. PubMed ID: 15086387
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lupus in infancy and childhood.
Lee LA
Lupus; 2010 Aug; 19(9):1112-7. PubMed ID: 20693205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
